Two hundred four intermediate-risk patients were divided into gastric group (Stom group) and non-gastric group (non-Stom group), we found significant differences between the two groups in gender, histological classification, tumor diameter, mitotic figures, Ki-67 index, and TKI treatment patterns. This evidence concerns the gene MKI67 and neoplasm.